Cerda, Alvaro; Fajardo, Cristina Moreno 
; Guimaraes, E. S; Dórea, Egidio Lima; Gosukuma, M. C; Pinto, Gelba Almeida; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo
Source: Abstracts. Conference titles: European Atherosclerosis Society Congress (EAS). Unidades: FCF, HU
Subjects: HIPERCOLESTEROLEMIA, CITOCINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CERDA, Alvaro et al. Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. 2013, Anais.. Gothenburg: European Atherosclerosis Society, 2013. . Acesso em: 13 nov. 2024.APA
Cerda, A., Fajardo, C. M., Guimaraes, E. S., Dórea, E. L., Gosukuma, M. C., Pinto, G. A., et al. (2013). Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. In Abstracts. Gothenburg: European Atherosclerosis Society.NLM
Cerda A, Fajardo CM, Guimaraes ES, Dórea EL, Gosukuma MC, Pinto GA, Hirata MH, Hirata RDC. Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. Abstracts. 2013 ;[citado 2024 nov. 13 ]Vancouver
Cerda A, Fajardo CM, Guimaraes ES, Dórea EL, Gosukuma MC, Pinto GA, Hirata MH, Hirata RDC. Low dose simvastatin plus ezetimibe treatment reduce inflammatory cytokines without modification of HSPCR levels in hypercholesterolemic patients. Abstracts. 2013 ;[citado 2024 nov. 13 ]
